USPTO Grants Codexis Patent for Enzymes Used in Hep-C Therapeutics
Highlights how Codexis platform enables breakthrough biocatalytic processes REDWOOD CITY, Calif.--(CRWENewswire)--Codexis, Inc. (Nasdaq:CDXS), a developer of cost-advantaged processes for the produc... [Read more]

